Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy

Ann Clin Biochem 2007;44:449-454
doi:10.1258/000456307781646076
© 2007 Association for Clinical Biochemistry

 

This Article
Right arrow

Full Text (PDF)

Right arrow
Alert me when this article is cited
Right arrow
Alert me if a correction is posted
Services
Right arrow
Email this article to a friend
Right arrow

Similar articles in this journal

Right arrow
Similar articles in PubMed
Right arrow
Alert me to new issues of the journal
Right arrow
Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow
Articles by Onishi, H.
Right arrow
Articles by Watanabe, T.
Right arrow Search for Related Content
PubMed
Right arrow
PubMed Citation
Social Bookmarking

What’s this?

Original Articles


Hiroaki Onishi,
Kimiko Kaniyu,
Mitsutoshi Iwashita,
Asashi Tanaka and
Takashi Watanabe


Department of Obsterics/Gynecology, Kyorin University, Tokyo, Japan;
Department of Clinical Pathology, Hachiouji Medical Center, Tokyo Medical University, Tokyo, Japan;
Department of Laboratory Medicine, Kyorin University, Tokyo, Japan


Background: Pregnancy represents a major risk factor for deepvein thrombosis (DVT). Most coagulation/fibrinolysis markerscurrently utilized change during pregnancy, and therefore theycannot accurately evaluate thrombotic events in pregnancy becausethe rate of false positive results is high. Fibrin monomer complex(FMC) has recently become widely available for diagnosing DVT.The present study examined whether FMC is suitable for evaluatingthrombotic status in pregnancy.

Methods: Concentrations of FMC and other haemostatic markerswere investigated in 87 pregnant women without major complicationsat early, mid- or late pregnancy. FMC concentrations were alsomeasured in 127 normal non-pregnant women, and in one womanwho developed DVT after delivery.

Results: In normal pregnant women, FMC concentrations were unchangedduring early or mid-pregnancy and slightly elevated during latepregnancy. Concentrations were within reference range in mostcases, and none exceeded the cut-off value for DVT. In contrast,thrombin-antithrombin complex (TAT) and D-dimer (DD) concentrationswere significantly elevated in late pregnancy, and median valuesexceeded reference ranges. The DVT case displayed significantlyelevated FMC concentrations.

Conclusions: Changes in FMC concentrations during normal pregnancyare minimal compared with other haemostatic markers. Becausethe rate of false positivity is lower, FMC could be a potentialmarker of thrombotic status in pregnancy rather than TAT andDD.


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?